The ASCO Post Podcast

Latest Episodes:

COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials Nov 20, 2020

Show notes

As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials.

Coverage of stories discussed this week on ascopost.com:

Serial COVID-19 Screening in Asymptomatic Patients Receiving Treatment for Cancer

Survey Finds Patients With Cancer May Be Less Likely to Enroll in Clinical Trials During the COVID-19 Pandemic

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Immune-Related Adverse Events and Survival Outcomes in NSCLC Nov 13, 2020

Show notes

This week, we’re focusing on lung cancer—first, with a report on how therapy-related adverse events experienced by patients with lung cancer treated with immunotherapy may help to predict survival outcomes; and second, with a video about disparities in certain populations when it comes to lung cancer screening and treatment.

Coverage of stories discussed this week on ascopost.com:

Multisystem Immune-Related Adverse Events and Disease Outcomes Among Patients With NSCLC Treated With Immunotherapy

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Prostate Cancer Highlights From the 2020 ASTRO Annual Meeting Nov 06, 2020

Show notes

This week, we're focusing on high-impact research in prostate cancer presented during the virtual 2020 ASTRO Annual Meeting.

The studies included a focus on GnRH receptor antagonist therapy; imaging-based guidance for radiotherapy intensification; and methods of radiotherapy boosts.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

2020 ASTRO Annual Meeting: High-Impact Research Oct 30, 2020

Show notes

This week, we’ll be featuring discussions of two late-breaking abstracts presented during the virtual 2020 American Society for Radiation Oncology, or ASTRO, Annual Meeting. The first focuses on the role of imaging to plan treatment with radiotherapy in patients with prostate cancer. The second discusses strategies to manage the pain of spinal metastases.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Recent FDA Approvals in Leukemia and Lymphoma Oct 23, 2020

Show notes

This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.

Coverage of stories discussed this week on ascopost.com:

FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML

FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma

To listen to more podcasts from ASCO, visit asco.org/podcasts.

First-Line Atezolizumab vs Chemotherapy for PD-L1–Positive Metastatic NSCLC Oct 16, 2020

Show notes

This week, we’ll review results of a trial that evaluated first-line anti–PD-L1 therapy vs platinum-based chemotherapy in patients with metastatic lung cancer and high PD-L1 expression. We’ll also discuss findings from a study that evaluated whether patients receiving care for advanced cancer based on the recommendations of a molecular tumor board tended to survive longer or experience more time without disease progression.

Coverage of stories discussed this week on ascopost.com:

First-Line Atezolizumab vs Chemotherapy in PD-L1–Positive Metastatic NSCLC: IMpower110

Cancer Therapy Based on Molecular Tumor Board Recommendations: Improvement in Outcomes?

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Breast Cancer News From the ESMO Virtual Congress 2020 Oct 09, 2020

Show notes

This week, we’ll be featuring our last disease-specific roundup from the ESMO Virtual Congress 2020. We’ll hear from three experts on their findings in breast cancer, focusing on results from two IMpassion trials as well as the efficacy of a novel antibody-drug conjugate in triple-negative disease, and a telehealth program for patients receiving chemotherapy.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Lung Cancer Reports From the ESMO Virtual Congress 2020 Oct 02, 2020

Show notes

This week, we’ll be reviewing results from several reports on lung cancer presented during the ESMO Virtual Congress 2020. The findings focus on the use of radiotherapy, biomarkers, targeted treatments, and immunotherapy.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers Sep 25, 2020

Show notes

This week, we’re hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We’ll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

ESMO Virtual Congress 2020: Findings in Breast and Head and Neck Cancers Sep 19, 2020

Show notes

This weekend, the ESMO Virtual Congress 2020 is underway, and we’re sharing interviews with two authors of high-impact papers on breast cancer and head and neck cancer presented at the event.

To listen to more podcasts from ASCO, visit asco.org/podcasts.